Health CanadaGeneral Alert
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
Published: April 14, 2022Recall ID: 64084Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
Recalling Firm: Marketed health products
Reason for Recall / Hazard
New safety information - COVID
Product Description & Identification
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
Affected Products
Sotrovimab, 500 mg IV
Additional Source Details
| Field | Value |
|---|---|
| N I D | 64084 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/sotrovimab-injection-risk-treatment-failure-due-circulation-sars-cov-2-omicron-ba2 |
| Issue | New safety information - COVID |
| Title | Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant |
| Product | Sotrovimab, 500 mg IV |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2022-04-14 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant Check if your household is affected: https://therecallfile.com/recalls/sotrovimab-for-injection-risk-of-treatment-failure-due-to-circulation/CANADA-64084
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordSotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant